278
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Development of a Point-of-Care Test Based on Selenium Nanoparticles for Heart-Type Fatty Acid-Binding Proteins in Human Plasma and Blood

, , , ORCID Icon, ORCID Icon, , , , & ORCID Icon show all
Pages 1273-1284 | Published online: 22 Mar 2022

References

  • Roth GA, Johnson C, Abajobir A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25. doi:10.1016/j.jacc.2017.04.052
  • Fathil MFM, Arshad MKM, Gopinath SCB, et al. Diagnostics on acute myocardial infarction: cardiac troponin biomarkers. Biosens Bioelectron. 2015;70:209–220.
  • Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J. Am Coll Cardiol. 2012;60:1581–1598.
  • Zhang D, Jiang C, Feng Y, et al. Molecular imaging of myocardial necrosis: an updated mini-review. J Drug Target. 2020;28(6):565–573.
  • Kim K, Park C, Kwon D, et al. Silicon nanowire biosensors for detection of cardiac troponin I (cTnI) with high sensitivity. Biosens Bioelectron. 2016;77:695–701.
  • Roffi M, Patrono C, Collet J, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of cardiology (ESC). G Ital Cardiol. 2016;17:831–872.
  • Shanmugam NR, Muthukumar S, Tanak AS, et al. Multiplexed electrochemical detection of three cardiac biomarkers cTnI, cTnT and BNP using nanostructured ZnO-sensing platform. Future Cardiol. 2018;14:131–141.
  • Savin M, Mihailescu CM, Matei I, et al. A quantum dot-based lateral flow immunoassay for the sensitive detection of human heart fatty acid binding protein (hFABP) in human serum. Talanta. 2018;178:910–915.
  • Fan J, Ma J, Xia N, et al. Clinical value of combined detection of CK-MB, MYO, cTnI and plasma NT-proBNP in diagnosis of acute myocardial infarction. Clin Lab. 2017;63:427–433.
  • Kleine AH, Glatz JFC, Van Nieuwenhoven FA, et al. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem. 1992;116:155–162.
  • Shanmugam NR, Muthukumar S, Chaudhry S, et al. Ultrasensitive nanostructure sensor arrays on flexible substrates for multiplexed and simultaneous electrochemical detection of a panel of cardiac biomarkers. Biosens Bioelectron. 2017;89:764–772.
  • Ren YG, Liu MC, Ji MZ, et al. Rapid detection of human heart-type fatty acid-binding protein in human plasma and blood using a colloidal gold-based lateral flow immunoassay. Exp Ther Med. 2021;22(5):1238.
  • Otaki Y, Watanabe T, Kubota I. Heart-type fatty acid-binding protein in cardiovascular disease: a systemic review. Clin Chim Acta. 2017;474:44–53.
  • Glatz JFC, van Bilsen M, Paulussen RJA, et al. Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta. 1988;961:148–152.
  • Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation. 1993;88:750–763.
  • Kabekkodu SP, Mananje SR, Saya RP. A study on the role of heart type fatty acid binding protein in the diagnosis of acute myocardial infarction. J Clin Diagn Res. 2016;10:OC07–OC10.
  • Vupputuri A, Sekhar S, Krishnan S, et al. Heart-type fatty acid-binding protein (H-FABP) as an early diagnostic biomarker in patients with acute chest pain. Indian Heart J. 2015;67:538–542.
  • Pyati AK, Devaranavadagi BB, Sajjannar SL, et al. Heart-type fatty acid binding protein: a better cardiac biomarker than CK-MB and myoglobin in the early diagnosis of acute myocardial infarction. J Clin Diagn Res. 2015;9:BC08–BC11.
  • Pyati AK, Devaranavadagi BB, Sajjannar SL, et al. Heart-type fatty acid-binding protein, in early detection of acute myocardial infarction: comparison with CK-MB, troponin I and myoglobin. Indian J Clin Biochem. 2016;31:439–445.
  • Valle HA, Riesgo LGC, Bel MS, et al. Clinical assessment of heart-type fatty acid binding protein in early diagnosis of acute coronary syndrome. Eur J Emerg Med. 2008;15:140–144.
  • Shabaiek A, Ismael NEH, Elsheikh S, et al. Role of cardiac myocytes heart fatty acid binding protein depletion (H-FABP) in early myocardial infarction in human heart (autopsy study). Open Access Maced J Med Sci. 2016;4:17–21.
  • Van Hise CB, Greenslade JH, Parsonage W, et al. External validation of heart-type fatty acid binding protein, high-sensitivity cardiac troponin, and electrocardiography as rule-out for acute myocardial infarction. Clin Biochem. 2018;52:161–163.
  • Bank IEM, Dekker MS, Hoes AW, et al. Suspected acute coronary syndrome in the emergency room: limited added value of heart type fatty acid binding protein point of care or ELISA tests: the FAME-ER (fatty acid binding protein in myocardial infarction evaluation in the emergency room) study. Eur Heart J Acute Cardiovasc Care. 2015;5:364–374.
  • Wang Z, Zhou Q, Guo Y, et al. Rapid detection of ractopamine and salbutamol in swine urine by immunochromatography based on selenium nanoparticles. Int J Nanomed. 2021;16:2059–2070.
  • Wang Z, Jing J, Ren Y, et al. Preparation and application of selenium nanoparticles in a lateral flow immunoassay for clenbuterol detection. Mater Lett. 2019;234:212–215.
  • Zhang J, Teng Z, Yuan Y, et al. Development, physicochemical characterization and cytotoxicity of selenium nanoparticles stabilized by beta-lactoglobulin. Int J Biol Macromol. 2018;107:1406–1413.
  • Niu MY, Fang Y, Gu WY. Synthesis of Selenium nanospheres using SDS-PEG cluster as soft template. J Jiangnan Univ. 2011;10:67–71.
  • Kong H, Yang J, Zhang Y, et al. Synthesis and antioxidant properties of gum arabic-stabilized selenium nanoparticles. Int J Biol Macromol. 2014;65:155–162.
  • Syed A, Ahmad A. Extracellular biosynthesis of CdTe quantum dots by the fungus Fusarium oxysporum and their anti-bacterial activity. Spectrochim acta A. 2013;106:41–47.
  • Senapati S, Syed A, Khan S, et al. Extracellular biosynthesis of metal sulfide nanoparticles using the fungus fusarium oxysporum. Curr Nanosci. 2014;10(4):588–595.
  • Syed A, AI Saedi MH, Bahkali AH, et al. αAu 2 S nanoparticles: fungal-mediated synthesis, structural characterization and bioassay. Green Chem Lett Rev. 2022;15(1):59–68.
  • Syed A, Al Saedi MH, Bahkali AH, et al. Biological synthesis of α-Ag2S composite nanoparticles using the fungus Humicola sp. and its biomedical applications. J Drug Deliv Sci Tec. 2021;22:102770.
  • Wen-de W, Min L, Ming C, et al. Development of a colloidal gold immunochromatographic strip for rapid detection of Streptococcus agalactiae in tilapia. Biosens Bioelectron. 2017;91:66–69.
  • Wang Z, Zheng Z, Hu H, et al. A point-of-care selenium nanoparticle-based test for the combined detection of anti-SARS-CoV-2 IgM and IgG in human serum and blood. Lab Chip. 2020;20(22):4255–4261.
  • Quesada-González D, Merkoçi A. Nanoparticle-based lateral flow biosensors. Biosens Bioelectron. 2015;73:47–63.
  • Chen C, Hu H, Li X, et al. Rapid detection of anti-SARS-CoV-2 antibody using a selenium nanoparticle-based lateral flow immunoassay. IEEE Trans Nanobiosci. 2022;21(1):37–43.
  • Wang Z, Zhi D, Zhang H, et al. Synthesis of selenium nanoparticles suitable for melamine detection using test strips. Nanosci Nanotec Let. 2015;7(8):617–622.
  • Liu X, Yuan Z, Tang Z, et al. Selenium-driven enhancement of synergistic cancer chemo/radiotherapy by targeting nanotherapeutics. Biomater Sci. 2021;9(13):4691–4700.
  • Cole LA. Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. Clin Chem. 1997;43:2233–2243.